Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1349-1356

  Singh, Leena K ^a   Boucher, William ^a   Pang, Xinzhu ^a   Letourneau, Richard ^a   Seretakis, Dimitri ^a   Green, Marlon ^a   Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTALARMIN; ASTRESSIN; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING HORMONE RECEPTOR 1 ANTAGONIST; HEXAMETHONIUM; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LIDOCAINE; NEUROTENSIN; SUBSTANCE P; UNCLASSIFIED DRUG; UROCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DOSE RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; HISTOPATHOLOGY; INTRADERMAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAST CELL DEGRANULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; RAT; RECEPTOR UPREGULATION; STRESS; VASODILATATION;

ANIMALS; CAPILLARY PERMEABILITY; CELL DEGRANULATION; CORTICOTROPIN-RELEASING HORMONE; EVANS BLUE; HISTAMINE; MALE; MAST CELLS; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SKIN;

EID: 0032982971     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Al'Abadie MS, Kent GG and Gawkrodger DJ (1994) The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol. 130:199-203.
2. Bamberger CM, Wald M, Bamberger A-M, Ergun S, Beil FU and Schulte HM (1998) Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab 83:708-711.
3. Boucher W, Singh L and Theoharides TC (1996) Differential effect of corticotropinreleasing hormone (CRH) on rat mast cell (MC) secretion (Abstract). FASEB J 10:A1290.
4. Castagliuolo I, LaMont JT, Qiu B, Fleming SM, Bhaskar KR, Nikulasson ST, Kornetsky C and Pothoulakis C (1996) Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am J Physiol 271:884-892.
5. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362.
6. Correa SG, Riera CM, Spiess J and Bianco ID (1997) Modulation of the inflammatory response by corticotropin-releasing factor. Eur J Pharmacol 318:85-90.
7. Dimitriadou V, Buzzi MG, Moskowitz MA and Theoharides TC (1991) Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells. Neuroscience 44:97-112.
8. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM and Vale WW (1996) Cloning and characterization of human urocortin. Endocrinology 137:2167-2170.
9. Foreman JC (1987) Neuropeptides and the pathogenesis of allergy. Allergy 42:1-11.
10. Galli SJ (1993) New concepts about the mast cell. N Engl J Med 328357-265.
11. Harvima IT, Naukkarinen A, Harvima RJ, Aalto M-L, Neittaanmaki H and Horsmanheimo M (1990) Quantitative enzyme-histochemical analysis of tryptase-and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 282:428-433.
12. Kaplan AP, Reddigari S, Baeza M and Kuna P (1991) Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv Immunol 50:237-260.
13. Karalis K, Louis JM, Bae D, Hilderbrand H and Majzoub JA (1997) CRH and the immune system. J Neuroimmunol 72:131-136.
14. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL and Chrousos GP (1991) Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science (Wash DC) 254:421-423.
15. Keller JT, Dimlich RV, Zuccarello M, Lanker L, Strauss TA and Fritts MJ (1991) Influence of the sympathetic nervous system as well as trigeminal sensory fibres on rat dural mast cells. Cephalalgia 11:215-221.
16. Kowalski ML and Kaliner MA (1988) Neurogenic inflammation, vascular permeability and mast cells. J Immunol 140:3905-3911.
17. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136:4139-4142.
18. Markowitz S, Saito K and Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 7:4129-4136.
19. Marquardt DL and Wasserman SI (1983) Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration. J Immunol 131:934-939.
20. Martinez V, Rivier J, Wang LX and Tache Y (1997) Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF-and stress-related alterations of gastric and colonic motor function. J Pharmacol Exp Ther 280:754-760.
21. Matsuda H, Kawakita K, Kiso Y, Nakano T and Kitamura Y (1989) Substance P induces granulocyte infiltration through degranulation of mast cells. J Immunol 142:927-931.
22. Merchenthaler I, Hynes MA, Vingh S, Schally AV and Petrusz P (1983) Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat spinal cord. Brain Res 275:373-377.
23. Reichlin S (1993) Neuroendocrine-immune interactions. N Engl J Med 329:1246-1253.
24. Rivest S, Laflamme N and Nappi RE (1995) Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci 15:2680-2695.
25. Roloff B, Fechner K, Slominski A, Furkert J, Botchkarev VA, Bulfone-Paus S, Zipper J, Krause E and Paus R (1998) Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J 12:287-297.
26. Skofitsch G, Zamir N, Heike CJ, Savitt JM Jacobowitz DM (1985) Corticotropin-releasing factor-like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: Colocalization with other neuropeptides. Peptides 6:307-318.
27. Slominski A, Ermak G, Hwang J, Chakraborty A, Mazurkiewicz JE and Mihm M (1995) Proopiomelanocortin, corticotropin-releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett 374: 113-116.
28. Slominski A, Ermak G, Hwang J, Mazurkiewicz J, Corliss D and Eastman A (1996) The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta 1289:247-251.
29. Slominski AJ, Ermak G, Mazurkiewicz JE, Baker J and Wortsman J (1998) Characterization of corticotropin-releasing hormone (CRH) in human akin. J Clin Endacrinol Metab 83:1020-1024.
30. Sperle K, Chen A, Kostich W, and Largent BL (1997) CRH2G: A novel CRH2 receptor isoform found in human brain (Abstract). Soc Neurosci Abstr 23:1765.
31. Suda T, Tomori N, Tozawa F, Mouri T, Demura H and Shizume K (1984) Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J Clin Endocrinol Metab 59:861-866.
32. Theoharides TC, Sieghart W, Greengard P and Douglas WW (1980) Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science (Wash DC) 207:80-2.
33. Theoharides TC (1990) Mast cells: The immune gate to the brain. Life Sci 46:607-617.
34. Theoharides TC, Singh L, Boucher W, Pang X, Letourneau R, Webster E and Chrousos G (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139:403-413.
35. Theoharides TC, Spanos CP, Pang X, Alferes L, Ligris K, Letourneau R, Rozniecki JJ, Webster E and Chrousos G (1995) Stress-induced intracranial mast cell degranulation: A corticotropin releasing hormone-mediated effect. Endocrinology 136:5745-5570.
36. Turnbull AV, Vale W and Rivier C (1996) Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur J Pharmacol 303:213-216.
37. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D and Rivier C (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature (London) 378:287-292.
38. WebsterEL, Lewis DB, Torpy DJ, Zachman EK, Rice KC and Chrousos GP (1996) In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137:5747-5750.
39. Williams RM, Bienenstock J and Stead RH (1995) Mast cells: The neuroimmune connection. Chem Immunol 61:208-235.